ABSTRACr The pa aiiq-solubilized fragment of the heavy chain of HLA-B7, which is the NHrterminal part of the whole polypeptide chain, can be divided into three regions by mild acid and cyanogen bromide cleavages. The first 100 amino acids terminating in a methionine residue contain the carboliydrate moiety; this segment is followed by two others of molecular weights 9,000 and 13,000, each containing an intrachain disulfide bridge. The two intrachain disulfide bridges are separated by a stretch of amino acids containing an acid-labile aspartylproline bond. Antigens of all EILA specificities tested thus far except HLA-A2, A28, and AW25 contain this acid-labile peptide bon in their larger subunit. Sequencing from the acid clavage site of HLA-B7 through the third half-cystine revealed considerable homology with amino acid sequences around a halfcystine in immunoglobulin variable regions. The products of the major histocompatibility complex in vertebrates display an important role in eliciting cellular and humoral immune responses (1, 2). The glycoproteins coded for by the classical H2K and H2D regions of the mouse and of the HLA-A and HLA-B regions in humans are thought to be the target sites for immuneattack on foreign tissue grafts (3, 4) . Moreover, these cell surface antigens are involved in the recognition by thymus-derived lymphocytes sensitized against virus-infected (5) or chemically modified (6) syngeneic cells. Knowledge of the chemical nature of the histocompatibility antigens is hence of considerable importance for our understanding of these and other cellular recognition processes.
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Several laboratories have shown that human and mouse histocompatibility antigens have a two-chain structure (7) (8) (9) (10) (11) .
A complex of a glycoprotein [molecular weight (Mr) 44,000] and 02-microglobulin (Mr 12,000) forms the antigenic entity, which is recognized by specific alloantisera (12) . In man the larger subunits of different serological specificities coded for by the HLA-A and HLA-B loci on chromosome six (13) show charge variability (14) . 032-Microglobulin coded for by a gene on chromosome fifteen (15) is invariant and shows structural homology with immunoglobulins (16, 17) . For this and other reasons it has been proposed that the larger subunit of HLA-A and HLA-B or H2K and H2D may have an immunoglobulinlike structure (18) (19) (20) . However, it is uncertain whether histocompatibility antigens have a four-chain structure on the cell surface as do immunoglobulins. Moreover, NH2-terminal sequences of these antigens gave only slight support to the notion of structural homology. The determination of NH2-terminal amino acid sequences in the Beckman sequencer were performed as described (24) . RESULTS Several HLA Specificities Contain an Acid-Labile Bond.
Treatment of the larger subunit of several HLA specificities with 70% formic acid cleaved the polypeptide chain into two fragments ( Fig. 1 ). This type of cleavage has been shown for various proteins to be due to an aspartylproline bond (30) (see below). The specificities B7, the mixture B7,12, and the mixture A3,W25,B12,27 were susceptible to acid treatment, whereas HLA-A2 was not. The limited amount of degradation that is apparent in HLA-A2 can be explained by the minor contamination of this preparation with HLA-B7 material. Several breakdown products other than the two major pieces arose, presumably from cleavage at aspartylglycine bonds (31 13 ,000 and 20,000) and hence were the COOH-terminal pieces. Moreover, on lectin affinity chromatography only the larger NH-terminal piece was retained, while the smaller COOH-terminal piece was in the flow-through of this column (Fig. 2) . Thus the carbohydrate was located in the NH2-terminal fragment, a fact that was confirmed by staining of the acid cleavage products with periodic acid/Schiff reagent (Fig. 4) ,
The presence of an acid-labile peptide bond in individual HLA-A and HLA-B specificities was further investigated after formation of immune complexes of 35S-labeled detergent-solubilized HLA-antigens with specific alloantisera. In addition to HLA-B7 and HLA-B12, three other HLA-B locus specificities were cleaved by acid (HLA-B17, B27, and BW40), yielding the two fragments of Mr heavy chain in the A3,W25,B12,27 preparation in Fig. 1 presumably includes most of the AW25 specificity in this preparation.
Arrangement of Disulfide Bridges in the Larger Polypeptide Chain of HLA-B7. Previous amino acid analyses and labeling experiments (24) indicated that the papain-solubilized HLA antigens contain two intrachain disulfide bridges. Chromatography of the acid-cleaved peptide mixture of HLA-B7pp on a Bio-Gel P-300 column in 6 M guanidine hydrochloride in the absence of reducing agent yielded the elution profile shown in Fig. 3A . An identical pattern was obtained when the larger polypeptide chain of HLA-B7pap was reduced and alkylated with iodo[14C]acetic acid prior to the treatment with formic acid. The radioactive label was equally distributed between the two main fragments (Fig. 3B ). This result is compatible only with a linear arrangement of the two intrachain disulfide bridges (see Fig. 5 below) . The same results were obtained by analysis of fragments by NaDodSO4 gel electrophoresis. Fig.  3C also shows that the fragments obtained from the Bio-Gel P-300 column were pure as judged by NaDodSO4 gel electrophoresis. Fractions B and E represent the NH2-terminal (23,000 Mr) and COOH-terminal (13,000) acid cleavage fragments, whereas C and D are the above-mentioned minor breakdown products.
Cyanogen Bromide Cleavage of HLA-B7. Amino acid compositions of fragments B and E (the acid cleavage products) demonstrate that each fragment contains two half-cystines and that the NH2-terminal fragment B contains two methionine residues. One of the methionines is known to be present at position 5 (24) . Thus, CNBr cleavage of purified fragment B gives rise to only two large pieces (Fig. 4) , one of which contains the two cysteines (9,000 Mr) whereas the other (14,000 Mr) can be stained with periodic acid/Schiff stain (Fig. 4A) (34) . The molecular weights of the various fragments are indicated. The papain cleavage sites were obtained from ref. 32 contains the asparagine-linked carbohydrate side chain (33) . Cyanogen bromide treatment converts methionine into a COOH-terminal homoserine residue (25) , the lactone of which can be formed by treatment with trifluoroacetic acid. Subsequent treatment with [14C]ethylenediamine (26) resulted in the incorporation of label into the 14,000 Mr but not the 9,000 Mr peptide. Hence the peptide of 14,000 Mr can be placed at the NH2-terminus of fragment B. In addition the NH2-terminal group of the 9,000 Mr cystine-containing fragment was found to be tyrosine and not arginine, as would be expected for the fragment starting at position 6 (24) . Treatment of the heavy chain of HLA-B7pap with acid and subsequent treatment with CNBr hence dissects the molecule into three parts-an NH2-terminal piece that contains the carbohydrate (14,000 Mr) and two fragments of 9,000 Mr and 13,000 Mr, each containing one intrachain disulfide bridge. The peptide molecular weight of the NH2-terminal fragment is estimated to be around 11,500, assuming a molecular weight of the glycan of around 2,500 (24, 33) .
The heavy chain from HLA-B7det was examined by the same techniques. The larger COOH-terminal fragment (Mr 20,000) treated with CNBr yields two pieces of Mr 17,000 and 3,000. The smaller of these is the COOH-terminus of the whole molecule as revealed by sequence analysis. This COOH-terminal fragment contains two additional cysteine residues that can be reduced and alkylated under mild conditions.*
The overall structure of the molecule deduced from cleavage with mild acid, CNBr, and papain is summarized in the model presented in Fig. 5 .
Partial NH2-Terminal Amino Acid Sequence of the Acid Cleavage Fragments of the Heavy Chain of HLA-B7pap. The NH2-terminal amino acid sequence of fragment E was determined in the Beckman automatic sequencer (Fig. 6 ). This amino acid sequence starts with a proline. Thus, the acid-labile bond in the heavy chain of several HLA specificities must be an aspartylproline bond. The 15th residue is a cysteine, the third cysteine in the heavy chain. A comparison of this sequence with immunoglobulin sequences around the intrachain half-cystine residues (34) Thr-Ser-Val-Ser-Arg-Pro-Gly-Arg-Gly-Glu-Pro-Pro-Phe-Ile- 25 30 Ala-Val-Gly-Tyr-Val-Asp-Gln-Thr. (32) . The peptide of 3,000 molecular weight which is the COOH-terminus of HLA-B7det (Fig. 4) is hydrophilic and contains two half-cystines that can be alkylated after mild reduction.* The amino acid sequence around the third half-cystine and the arrangement of the intrachain disulfide bridges support the notion that HLA antigens and immunoglobulins have a common evolutionary origin. The relative locations of the homologous regions are somewhat puzzling and more data are needed to postulate a genetic mechanism explaining this phenomenon.
Two general classes of molecules have been shown to share some structural properties with immunoglobulins. The first group, which includes haptoglobins (35) and C-reactive proteins (36) , has amino acid sequence homology with immunoglobulins. Haptoglobins are of interest because the limited homology of these molecules with immunoglobulins involves the sequences around the second half-cystine of the variable regions. These similarities of sequence of HLA, haptoglobins, and immunoglobulins may simply reflect a particular folding pattern of these molecules about certain cysteine residues. The other class of proteins, in which the structural similarities are of a somewhat different kind, is exemplified by superoxide dismutase (37) , which has an immunoglobulin-like folding pattern of antiparallel (3 strands forming a bilayer structure but fails to demonstrate sequence homologies with immunoglobulins. The amino acid sequence of 32-microglobulin suggests that it as well has a folding pattern similar to that of immunoglobulin domains and has led to the suggestion that the larger subunit of HLA shares this Ig-like conformational pattern. The HLA antigens may therefore share both sequence and conformational features with immunoglobulins, although whether this is related to functional or evolutionary similarities between these two groups of molecules is as yet unclear. It will be of interest in this context to see whether other products of the major histocompatibility complex share these overall features.
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